TNF and inflammatory bowel disease: The recognition of tumor necrosis factor (TNF) as a key proinflammatory cytokine in Crohn’s disease (CD) and ulcerative colitis (UC) and the subsequent development of biologic drugs targeting TNF have redefined the management of inflammatory bowel disease (IBD).